Company intelligence / Profile preview

Sayre Therapeutics

Bengaluru (Bangalore), Karnataka, India

Ownership: Private
Employees: ~34
Development stage: Other

Overview

Sayre Therapeutics is a commercial-stage specialty healthcare company that in-licenses and commercializes novel oncology, rare and orphan disease medicines, drug-delivery devices, biosimilars, niche generics, and companion/other diagnostics across India, South Asia, and parts of Southeast Asia; detailed program-level clinical results are not publicly described.

Therapeutic areas: OncologyImmunologyRheumatologyRare Diseases
Modalities: Small moleculeRecombinant proteinMonoclonal antibodyDrug-delivery deviceDiagnostic
Industry: Biotech

Drug pipeline

5 assets

RasCase

Unknown

4 more assets in the full pipeline.

Request access →

Partnerships

Multiple unnamed global licensors for US/EU/Japan-approved drugs brought to India and South Asia (names not specified on public site)

Beyond the preview

Go deeper on Sayre Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sayre Therapeutics.

Explore the full profile